Literature DB >> 34480115

Threshold thickness of foveal outer nuclear layer associated with outcomes of photodynamic therapy in central serous chorioretinopathy.

Qing Chang1,2,3,4, Gezhi Xu5,6,7,8, Jia Yu9,10,11,12, Xiaofeng Ye9,10,11,12, Lei Li9,10,11,12, Chunhui Jiang9,10,11,12.   

Abstract

OBJECTIVES: To investigate the threshold thickness of the foveal outer nuclear layer (ONL) associated with favourable visual outcome after half-dose photodynamic therapy (PDT) in patients with central serous chorioretinopathy (CSC).
METHODS: The CSC patients were divided into two groups according to whether their best-corrected visual acuity (BCVA) at 1 year after half-dose PDT was 20/20 or worse than 20/20. Three multivariable logistic regression models were respectively created to determine the prognostic value of the pre-PDT foveal ONL thickness, the pre- and the post-PDT foveal ONL thickness ratio, which was defined as the foveal ONL thickness in the CSC eye to that in the normal contralateral eye, for predicting the outcome of half-dose PDT. The areas under the receiver operating characteristic curves (AUCs) were compared and the best cut-off values were determined, respectively.
RESULTS: Totally, 134 patients were included. The pre-PDT foveal ONL thickness, the pre-PDT and the post-PDT foveal ONL thickness ratios were all independent predictors of the outcome after half-dose PDT in their respective model (all P < 0.05). The AUC of the post-PDT foveal ONL thickness ratio was significantly higher than the AUCs of the other two parameters (0.940 vs 0.840 and 0.882, DeLong test: both P < 0.05), with the cut-off value of 0.81.
CONCLUSIONS: The threshold of the foveal ONL thickness ratio is 0.81. Active CSC eyes with a foveal ONL thickness ratio of 0.81 or more could probably retain BCVA of 20/20 after half-dose PDT. They were considered reasonable to wait for spontaneous resolution of sub-retinal fluid.
© 2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Entities:  

Year:  2021        PMID: 34480115      PMCID: PMC9500008          DOI: 10.1038/s41433-021-01762-0

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   4.456


  22 in total

1.  Central serous chorioretinopathy: a personal perspective.

Authors:  Lawrence A Yannuzzi
Journal:  Am J Ophthalmol       Date:  2010-03       Impact factor: 5.258

2.  Macular perfusion in healthy Chinese: an optical coherence tomography angiogram study.

Authors:  Jian Yu; Chunhui Jiang; Xiaolei Wang; Li Zhu; Ruiping Gu; Huan Xu; Yali Jia; David Huang; Xinghuai Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

3.  Apoptotic photoreceptor degeneration in experimental retinal detachment.

Authors:  B Cook; G P Lewis; S K Fisher; R Adler
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-05       Impact factor: 4.799

4.  Experience with nontreatment of central serous choroidopathy.

Authors:  M L Klein; E M Van Buskirk; E Friedman; E Gragoudas; S Chandra
Journal:  Arch Ophthalmol       Date:  1974-04

5.  Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study.

Authors:  T Y Y Lai; W-M Chan; H Li; R Y K Lai; D T L Liu; D S C Lam
Journal:  Br J Ophthalmol       Date:  2006-04-05       Impact factor: 4.638

6.  Half-dose photodynamic therapy targeting the leakage point on the fluorescein angiography in acute central serous chorioretinopathy: a pilot study.

Authors:  Kyu Seop Kim; Won Ki Lee; Seung Bum Lee
Journal:  Am J Ophthalmol       Date:  2013-11-01       Impact factor: 5.258

7.  CORRELATIONS BETWEEN CHANGES IN PHOTORECEPTOR LAYER AND OTHER CLINICAL CHARACTERISTICS IN CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Jia Yu; Chunhui Jiang; Gezhi Xu
Journal:  Retina       Date:  2019-06       Impact factor: 4.256

8.  The relationship between foveal outer nuclear layer thickness in the active and resolved phases of central serous chorioretinopathy treated with half-dose photodynamic therapy.

Authors:  Jia Yu; Yuan Lei; Qing Chang; Gezhi Xu; Xiaofeng Ye; Lei Li; Chunhui Jiang
Journal:  BMC Ophthalmol       Date:  2019-03-29       Impact factor: 2.209

9.  Inter- and Intra-individual Variations in Foveal Outer Nuclear Layer Thickness and Their Associations with Clinical Characteristics in a Healthy Chinese Population.

Authors:  Jia Yu; Lei Li; Chunhui Jiang; Qing Chang; Qi Zhao
Journal:  J Ophthalmol       Date:  2020-05-24       Impact factor: 1.909

10.  Relationship between photoreceptor layer changes before half-dose photodynamic therapy and functional and anatomic outcomes in central serous chorioretinopathy.

Authors:  Jia Yu; Xiaofeng Ye; Lei Li; Qing Chang; Chunhui Jiang
Journal:  Eye (Lond)       Date:  2020-06-16       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.